ESSA Pharma Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
24
- Latest Deal Type
-
M&A
- Financing Rounds
-
15
- Investments
-
1
ESSA Pharma General Information
Description
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
Contact Information
Website
www.essapharma.comCorporate Office
- 999 West Broadway
- Suite 720
- Vancouver, British Columbia V5Z 1K5
- Canada
Corporate Office
- 999 West Broadway
- Suite 720
- Vancouver, British Columbia V5Z 1K5
- Canada
ESSA Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ESSA Pharma Comparisons
Industry
Financing
Details
ESSA Pharma Competitors (33)
One of ESSA Pharma’s 33 competitors is Geron, a Formerly VC-backed company based in Foster City, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Geron | Formerly VC-backed | Foster City, CA | ||||
| Agenus | Formerly VC-backed | Lexington, MA | ||||
| Xenetic Biosciences | Corporation | Framingham, MA | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Bristol-Myers Squibb | Corporation | Princeton, NJ |
ESSA Pharma Patents
ESSA Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024006207-A1 | An n-terminal domain androgen receptor inhibitor and uses thereof | Inactive | 26-Jun-2022 | ||
| AU-2023255575-A1 | Androgen receptor modulators and methods for their use | Pending | 22-Apr-2022 | ||
| US-20230373934-A1 | Androgen receptor modulators and methods for their use | Inactive | 22-Apr-2022 | ||
| WO-2023205507-A1 | Androgen receptor modulators and methods for their use | Inactive | 22-Apr-2022 | ||
| WO-2023056423-A1 | Androgen receptor modulators and methods for use as bifunctional degraders | Inactive | 30-Sep-2021 | C07D401/14 |
ESSA Pharma Signals
ESSA Pharma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
ESSA Pharma Acquisitions (1)
ESSA Pharma’s most recent deal was a Merger/Acquisition with Realm Therapeutics for . The deal was made on 31-Jul-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Realm Therapeutics | 31-Jul-2019 | Merger/Acquisition | Drug Discovery |
ESSA Pharma FAQs
-
When was ESSA Pharma founded?
ESSA Pharma was founded in 2009.
-
Where is ESSA Pharma headquartered?
ESSA Pharma is headquartered in Vancouver, Canada.
-
What is the size of ESSA Pharma?
ESSA Pharma has 24 total employees.
-
What industry is ESSA Pharma in?
ESSA Pharma’s primary industry is Drug Discovery.
-
Is ESSA Pharma a private or public company?
ESSA Pharma is a Private company.
-
What is ESSA Pharma’s current revenue?
The current revenue for ESSA Pharma is .
-
How much funding has ESSA Pharma raised over time?
ESSA Pharma has raised $191M.
-
Who are ESSA Pharma’s investors?
BB Biotech, Cancer Prevention and Research Institute of Texas, Deerfield Management, Five Stones Investment Group, and Frazier Healthcare Partners are 5 of 10 investors who have invested in ESSA Pharma.
-
Who are ESSA Pharma’s competitors?
Geron, Agenus, Xenetic Biosciences, Adaptimmune Therapeutics, and Bristol-Myers Squibb are some of the 33 competitors of ESSA Pharma.
-
When was ESSA Pharma acquired?
ESSA Pharma was acquired on 09-Oct-2025.
-
Who acquired ESSA Pharma?
ESSA Pharma was acquired by XenoTherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process